(Cys¹⁸)-Atrial Natriuretic Factor (4-18) amide contains an engineered cysteine to explore disulfide-mediated stability in natriuretic fragments. Its sequence aids mapping of helical and loop motifs relevant to receptor binding. Researchers analyze its structural behavior to evaluate residue contributions. The salt form supports reproducible biochemical handling.
CAT No: A17037
CAS No:111863-73-1
Synonyms/Alias:(Cys¹⁸)-Atrial Natriuretic Factor (4-18) amide (mouse, rabbit, rat) trifluoroacetate salt;
1. High fat diet and GLP-1 drugs induce pancreatic injury in mice
2. Emu oil in combination with other active ingredients for treating skin imperfections
4. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.